1. Home
  2. PMCB vs HIHO Comparison

PMCB vs HIHO Comparison

Compare PMCB & HIHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMCB
  • HIHO
  • Stock Information
  • Founded
  • PMCB 1996
  • HIHO 1990
  • Country
  • PMCB United States
  • HIHO Hong Kong
  • Employees
  • PMCB N/A
  • HIHO N/A
  • Industry
  • PMCB Biotechnology: Biological Products (No Diagnostic Substances)
  • HIHO Industrial Machinery/Components
  • Sector
  • PMCB Health Care
  • HIHO Industrials
  • Exchange
  • PMCB Nasdaq
  • HIHO Nasdaq
  • Market Cap
  • PMCB 6.7M
  • HIHO 7.8M
  • IPO Year
  • PMCB N/A
  • HIHO 1996
  • Fundamental
  • Price
  • PMCB $1.04
  • HIHO $1.67
  • Analyst Decision
  • PMCB
  • HIHO
  • Analyst Count
  • PMCB 0
  • HIHO 0
  • Target Price
  • PMCB N/A
  • HIHO N/A
  • AVG Volume (30 Days)
  • PMCB 121.2K
  • HIHO 197.8K
  • Earning Date
  • PMCB 09-15-2025
  • HIHO 10-10-2025
  • Dividend Yield
  • PMCB N/A
  • HIHO 7.21%
  • EPS Growth
  • PMCB N/A
  • HIHO N/A
  • EPS
  • PMCB 0.01
  • HIHO 0.01
  • Revenue
  • PMCB N/A
  • HIHO $7,080,000.00
  • Revenue This Year
  • PMCB N/A
  • HIHO N/A
  • Revenue Next Year
  • PMCB N/A
  • HIHO N/A
  • P/E Ratio
  • PMCB $163.65
  • HIHO $171.89
  • Revenue Growth
  • PMCB N/A
  • HIHO 3.31
  • 52 Week Low
  • PMCB $0.80
  • HIHO $1.40
  • 52 Week High
  • PMCB $2.42
  • HIHO $2.88
  • Technical
  • Relative Strength Index (RSI)
  • PMCB 52.01
  • HIHO 48.22
  • Support Level
  • PMCB $0.94
  • HIHO $1.62
  • Resistance Level
  • PMCB $1.06
  • HIHO $1.73
  • Average True Range (ATR)
  • PMCB 0.08
  • HIHO 0.04
  • MACD
  • PMCB 0.00
  • HIHO -0.00
  • Stochastic Oscillator
  • PMCB 38.16
  • HIHO 40.23

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

About HIHO Highway Holdings Limited

Highway Holdings Ltd is a holding company. Along with its subsidiaries, it operates as a fully integrated manufacturer of high-quality metal, plastic, electric and electronic components, subassemblies, and finished products for OEMs and contract manufacturers. The manufacturing services offered by the group include metal stamping, screen printing, plastic injection molding, pad printing, and electronic assembly of printed circuit boards. Its reportable business segments are metal stamping and mechanical OEM operations, which derive maximum revenue, and electric OEM operations. Geographically, the group generates maximum revenue from Europe, and the rest from North America, Hong Kong and China, and other Asian countries.

Share on Social Networks: